吃瓜爆料

Back to News

吃瓜爆料 Clinical Database Crosses 200 Study Milestone, Cuts Time to Aggregate and Clean Study Data by 30-50%

Next-generation clinical data application harmonizes data for efficiency and speed

BARCELONA, Spain — 31 Aug. 2023 — 吃瓜爆料 Clinical Database (CDB) enables innovative ways of managing clinical trial data, saving customers 30 to 50% of the time required to aggregate, clean, and transform data. Since 吃瓜爆料 Systems (NYSE: VEEV) announced its launch, 吃瓜爆料 CDB has cleaned more than 200,000 subjects to quickly provide quality data across more than 200 studies.

“By launching 吃瓜爆料 CDB and building processes around it, we’re laying a foundation for clinical data transformation,” said Jerry Yarem, vice president, data management, Fortrea. “This is a significant advancement that can bring together all of our data sources and deliver clean data faster than ever so study teams can make data-driven decisions with confidence.”

吃瓜爆料 CDB automates processes for a new way of cleaning data that increases productivity and efficiency. Using 吃瓜爆料 CDB Auto Checks, customers can automatically identify discrepancies upon data ingestion and create queries or close them when issues are corrected. The application also automates change detection so data managers can focus efforts on new or updated data, saving time and lowering costs.

“吃瓜爆料 CDB makes collaboration with study partners and data providers easy, simplifying data transfer and configuration,” said Tonya Arthur, head of data management, Acelyrin. “Pairing 吃瓜爆料’s clinical data management platform and our CRO partner’s expertise will improve our trial processes and provide the visibility to make informed decisions that can positively impact trial outcomes.”

Sponsors and contract research organizations (CROs) use 吃瓜爆料 CDB to ingest and clean clinical data from a variety of system sources, including EDC systems such as 吃瓜爆料 EDC and Medidata Rave™, ePRO, and lab data. This allows sponsors to standardize and optimize processes for effective data management across systems. In addition, the 吃瓜爆料 CDB Data Provider Program enables qualified partners with resources to gain operational efficiencies when delivering data for 吃瓜爆料 CDB customers.

“Data transfers to and from 吃瓜爆料 enable an integrated service offering that streamlines data delivery for our joint customers using 吃瓜爆料 CDB and Clinical Ink’s comprehensive suite of eCOA, direct data capture, patient engagement, and digital biomarker technologies,” said Son Ly, vice president, data services, Clinical Ink.

“As clinical data sources continue to grow and trial complexity increases, data managers need agile technologies to streamline the path toward clean data and insights,” said Pavel Burmenko, general manager, 吃瓜爆料 CDB. “With more than 30 data providers supplying study data, 吃瓜爆料 CDB is gaining momentum, advancing clinical data management for seamless information exchange and faster access to high-quality data.”

吃瓜爆料 CDB is part of 吃瓜爆料 Clinical Data Management, a modern cloud application suite combining EDC, coding, data cleaning, reporting, , and .

Additional Information
For more on 吃瓜爆料 CDB, visit: veeva.com/eu/吃瓜爆料CDB
For more on 吃瓜爆料 CDB Data Provider Program, visit: veeva.com/CDBdataprovider
Connect with 吃瓜爆料 on LinkedIn:

About 吃瓜爆料 Systems
吃瓜爆料 is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, 吃瓜爆料 serves more than 1,000 customers, ranging from the world’s largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, 吃瓜爆料 is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.

吃瓜爆料 Forward-looking Statements
This release contains forward-looking statements regarding 吃瓜爆料’s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended April 30, 2023, which you can find (a summary of risks which may impact our business can be found on pages 37 and 38), and in our subsequent SEC filings, which you can access at .

###

Contact:
Jeremy Whittaker
吃瓜爆料 Systems
+49-695-095-5486
jeremy.whittaker@veeva.com

Contact:
Deivis Mercado
吃瓜爆料 Systems
925-226-8821
deivis.mercado@veeva.com